Similar efficacy of ciclesonide once daily versus fluticasone propionate twice daily in patients with persistent asthma

Journal of Asthma

Volumn 44, Issue 7, 2007, Pages 555-563

  Magnussen, Helgo ^a   Hofman, Jerzy ^b   Staneta, Pawel ^c   Lawo, John Philip ^d   Hellwig, Michael ^d   Engelstätter, Renate ^d  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

^b Children's Hospital   (Poland)

^c Specjalistyczna Przychodnia Lekarska   (Poland)

^d ALTANA PHARMA AG   (Germany)

Author keywords

Asthma; Ciclesonide; Fluticasone propionate; Inhaled corticosteroid; Local side effects

Indexed keywords

CICLESONIDE; FLUTICASONE PROPIONATE;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BRONCHITIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHARYNGITIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCHOOL CHILD; SYMPTOM;

ADOLESCENT; ADULT; AGED; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; ASTHMA; CHILD; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREGNENEDIONES; RESPIRATORY FUNCTION TESTS;

EID: 34548819956     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900701537081     Document Type: Article

References (39)

1. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343:332-336.
2. Hanania NA, Chapman KR, Kesten S. Adverse effects of inhaled corticosteroids. Am J Med 1995; 98:196-208.
3. Georgitis JW. The 1997 Asthma Management Guidelines and therapeutic issues relating to the treatment of asthma. National Heart, Lung, and Blood Institute. Chest 1999; 115:210-217.
4. Barnes PJ. Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma. J Allergy Clin Immunol 1998; 101:S427-433.
5. Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001; 107:937-944.
6. Toogood JH. Side effects of inhaled corticosteroids. J Allergy Clin Immunol 1998; 102:705-713.
7. Global asthma physician and patient (GAPP) survey. 2006. 〈www.gappsurvey.org〉. Last accessed 2006.
8. Barnes PJ. The role of inflammation and anti-inflammatory medication in asthma. Respir Med 2002; 96 Suppl A:S9-15.
9. Busse WW, Rosenwasser LJ. Mechanisms of asthma. J Allergy Clin Immunol 2003; 111:S799-804.
10. Hansel TT, Barnes PJ. Novel drugs for treating asthma. Curr Allergy Asthma Rep 2001; 1:164-173.
11. Mann M, Eliasson O, Patel K, ZuWallack RL. A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. Chest 1992; 101:496-499.
12. Belvisi MG, Hele DJ. Soft steroids: a new approach to the treatment of inflammatory airways diseases. Pulm Pharmacol Ther 2003; 16:321-325.
13. Stoeck M, Riedel R, Hochhaus G, Hafner D, Masso JM, Schmidt B, et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J Pharmacol Exp Ther 2004; 309:249-258.
14. Rohatagi S, Arya V, Zech K, Nave R, Hochhaus G, Jensen BK, et al. Population pharmacokinetics and pharmacodynamics of ciclesonide. J Clin Pharmacol 2003; 43:365-378.
15. Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma. Chest 2005; 127:851-860.
16. Rohatagi S, Appajosyula S, Derendorf H, Szefler S, Nave R, Zech K, et al. Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/ pharmacodynamic perspective. J Clin Pharmacol 2004; 44:37-47.
17. Postma DS, Sevette C, Martinat Y, Schlosser N, Aumann J, Kafe H. Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. Eur Respir J 2001; 17:1083-1088.
18. Chapman KR, Patel P, D'Urzo AD, Alexander M, Mehra S, Oedekoven C, et al. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma. Allergy 2005; 60:330-337.
19. Derom E, Van De Velde V, Marissens S, Engelstatter R, Vincken W, Pauwels R. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5 monophosphate in asthmatic patients. Pulm Pharmacol Ther 2005; 18:328-336.
20. Chapman KR, Patel P, Boulet LP, D'Urzo AD, Alexander M, Mehra S, et al. Efficacy and long-term safety of ciclesonide in asthmatic patients as demonstrated in a 52 week long study. Eur Respir J 2002; 20 (Suppl. 38): 373s.
21. Pearlman DS, Berger WE, Kerwin E, Laforce C, Kundu S, Banerji D. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma. J Allergy Clin Immunol 2005; 116:1206-1212.
22. Buhl R, Vinkler I, Magyar P, Gyori Z, Rybacki C, Middle MV, et al. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma. Pulm Pharmacol Ther 2006; 19:404-412.
23. Guidelines for the evaluation of impairment/disability in patients with asthma. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 1993; 147:1056-1061.
24. Chervinsky P, van As A, Bronsky EA, Dockhorn R, Noonan M, LaForce C, et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group. J Allergy Clin Immunol 1994; 94:676-683.
25. Sheffer AL, LaForce C, Chervinsky P, Pearlman D, Schaberg A. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group. J Fam Pract 1996; 42:369-375.
26. Wolfe JD, Selner JC, Mendelson LM, Hampel F, Jr., Schaberg A. Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study. Clin Ther 1996; 18:635-646.
27. Purucker ME, Rosebraugh CJ, Zhou F, Meyer RJ. Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day. Chest 2003; 124:1584-1593.
28. Nave R, Fisher R, Zech K. In Vitro metabolism of ciclesonide in human lung and liver precision-cut tissue slices. Biopharm Drug Dispos 2006; 27:197-207.
29. Issar M, Sahasranaman S, Buchwald P, Hochhaus G. Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids. Eur Respir J 2006; 27:511-516.
30. Miller-Larsson A, Mattsson H, Hjertberg E, Dahlback M, Tunek A, Brattsand R. Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue. Drug Metab Dispos 1998; 26:623-630.
31. Bisgaard H, Allen D, Milanowski J, Kalev I, Willits L, Davies P. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 2004; 113:e87-e94.
32. Derendorf H, Hochhaus G, Meibohm B, Mollmann H, Barth J. Pharmacokinetics and pharmacodynamics of inhaled corticosteroids. J Allergy Clin Immunol 1998; 101:S440-S446.
33. Mollmann H, Wagner M, Meibohm B, Hochhaus G, Barth J, Stockmann R, et al. Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration. Eur J Clin Pharmacol 1998; 53:459-467.
34. LaForce CF, Pearlman DS, Ruff ME, Silvers WS, Weinstein SW, Clements DS, et al. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma. Ann Allergy Asthma Immunol 2000; 85:407-415.
35. Santanello NC, Zhang J, Seidenberg B, Reiss TF, Barber BL. What are minimal important changes for asthma measures in a clinical trial? Eur Respir J 1999; 14:23-27.
36. Boulet LP, Cowie RL, Negro RD, Brett W, Gold M, Marques A, et al. Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthma. Can Respir J 2000; 7:239-247.
37. Reynolds NA, Scott LJ. Ciclesonide. Drugs 2004; 64:511-9; discussion 20-21.
38. Lipworth BJ, Kaliner MA, LaForce CF, Baker JW, Kaiser HB, Amin D, et al. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma. Ann Allergy Asthma Immunol 2005; 94:465-472.
39. Richter K, Kanniess F, Biberger C, Nave R, Magnussen H. Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma. J Clin Pharmacol 2005; 45:146-152.